ALDX
Aldeyra Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.36
−1.45%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-33.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 11, 2026 | Walker Neal · director | A-Award | 70,000 | $1.72 |
| Jun 11, 2026 | Clark William D · director | A-Award | 2,323 | $1.72 |
| Jun 11, 2026 | Clark William D · director | A-Award | 70,000 | $1.72 |
| Jun 11, 2026 | Phillips Gary M. · director | A-Award | 4,977 | $1.72 |
| Jun 11, 2026 | Phillips Gary M. · director | A-Award | 6,636 | $1.72 |
| Jun 11, 2026 | Phillips Gary M. · director | A-Award | 70,000 | $1.72 |
| Jun 11, 2026 | DOUGLAS RICHARD · director | A-Award | 2,323 | $1.72 |
| Jun 11, 2026 | DOUGLAS RICHARD · director | A-Award | 19,909 | $1.72 |
| Jun 11, 2026 | DOUGLAS RICHARD · director | A-Award | 70,000 | $1.72 |
| Jun 11, 2026 | Miller-Rich Nancy · director | A-Award | 3,318 | $1.72 |
| Jun 11, 2026 | Miller-Rich Nancy · director | A-Award | 70,000 | $1.72 |
| Jun 11, 2026 | DEPTULA-HICKS DARLENE M · director | A-Award | 9,756 | $1.72 |
| Jun 11, 2026 | DEPTULA-HICKS DARLENE M · director | A-Award | 84,557 | $1.72 |
| Jun 11, 2026 | Bronstein Ben · director | A-Award | 4,977 | $1.72 |
| Jun 11, 2026 | Bronstein Ben · director | A-Award | 5,309 | $1.72 |
| Jun 11, 2026 | Bronstein Ben · director | A-Award | 70,000 | $1.72 |
| Jun 11, 2026 | Walker Neal · director | A-Award | 3,318 | $1.72 |
| Jun 5, 2026 | Brady Todd C · director, officer: President and CEO | Purchase | 250,000 | $1.67 |
| Mar 31, 2026 | Brady Todd C · director, officer: President and CEO | A-Award | 632,318 | $0.00 |
| Mar 31, 2026 | Brady Todd C · director, officer: President and CEO | A-Award | 1,880,510 | $1.77 |
| Mar 20, 2026 | DOUGLAS RICHARD · director | Purchase | 70,000 | $1.40 |
| Mar 19, 2026 | Alfieri Michael · officer: Principal Financial Officer | Purchase | 5,000 | $1.42 |
| Aug 15, 2025 | Alfieri Michael · officer: Principal Financial Officer | Purchase | 2,500 | $5.30 |
| Aug 13, 2025 | Machatha Stephen · officer: Chief Development Officer | Sale | 22,073 | $5.15 |
| Jun 12, 2025 | DOUGLAS RICHARD · director | A-Award | 1,689 | $2.69 |
| Jun 12, 2025 | Miller-Rich Nancy · director | A-Award | 62,728 | $2.69 |
| Jun 12, 2025 | Miller-Rich Nancy · director | A-Award | 2,413 | $2.69 |
| Jun 12, 2025 | Bronstein Ben · director | A-Award | 62,728 | $2.69 |
| Jun 12, 2025 | Bronstein Ben · director | A-Award | 3,860 | $2.69 |
| Jun 12, 2025 | Bronstein Ben · director | A-Award | 3,619 | $2.69 |
Institutional positioning
13F filings over the trailing two quarters
New 41Increased 82Reduced 81Sold out 38
| Filer | Action | Shares | Filed |
|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | Unchanged | 5,475,516 | May 15, 2026 |
| Knoll Capital Management, LLC | Unchanged | 5,475,516 | Sep 10, 2026 |
| BLACKROCK, INC. | Reduced | 3,763,887 | May 13, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 3,751,558 | Aug 14, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 2,829,875 | May 15, 2026 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | Increased | 2,652,315 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,363,742 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 2,361,796 | Aug 13, 2026 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | Increased | 2,152,315 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Increased | 1,940,338 | Aug 14, 2026 |
| MARSHALL WACE, LLP | Increased | 1,506,974 | Aug 13, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Reduced | 1,500,000 | May 15, 2026 |
| 683 Capital Management, LLC | Reduced | 1,450,000 | Aug 14, 2026 |
| D. E. SHAW & CO., INC. | Reduced | 1,403,990 | May 15, 2026 |
| JANE STREET GROUP, LLC | Increased | 1,396,415 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 11, 2026